Literature DB >> 7484191

Abulia and impulsiveness revisited: a conceptual history.

G E Berrios1, M Gili.   

Abstract

Historical analysis suggests that the decline and fall of the will was due not to any major piece of empirical work demonstrating that the concept was unsound but to general changes in philosophical fashion, and to the temporary influence of the anti-mentalistic tenets of behaviorism and the anti-volitional assumptions of psychoanalysis. Clinical disorders like abulia and impulsiveness share conceptual features that 19th-century alienists captured well in their clinical category of disorder of the will. Current accounts, which include semi-explanatory concepts such as "drive", "motivation" or frontal lobe "executive" are not conceptually better than the old notion of will nor are they superior as correlational variables for neurobiological studies. It is suggested that the will, updated according to modern work in the philosophy of action, be re-adopted as a research category in current psychiatry.

Entities:  

Mesh:

Year:  1995        PMID: 7484191     DOI: 10.1111/j.1600-0447.1995.tb09561.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  4 in total

Review 1.  [Disorders of the will in psychopathology].

Authors:  T Fuchs; D Broschmann
Journal:  Nervenarzt       Date:  2017-11       Impact factor: 1.214

2.  The Validity of the WHO-5 as an Early Screening for Apathy in an Elderly Population.

Authors:  Ramona Lucas-Carrasco; Peter Allerup; Per Bech
Journal:  Curr Gerontol Geriatr Res       Date:  2012-09-10

3.  Do Event-Related Evoked Potentials Reflect Apathy Tendency and Motivation?

Authors:  Hiroyuki Takayoshi; Keiichi Onoda; Shuhei Yamaguchi
Journal:  Front Hum Neurosci       Date:  2018-01-31       Impact factor: 3.169

Review 4.  Neurobehavioral Initiation and Motivation Problems After Acquired Brain Injury.

Authors:  Simona Palmisano; Luciano Fasotti; Dirk Bertens
Journal:  Front Neurol       Date:  2020-02-21       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.